ReviewLimitations of non-invasive tests for assessment of liver fibrosis
Under a Creative Commons license
open access
Keywords
Liver biopsy
Biomarkers
Elastography
Viral hepatitis
Non-alcoholic fatty liver disease
Abbreviations
AGA
American Gastroenterology Association
ALT
alanine aminotransferase
APRI
AST-platelet ratio index
AST
aspartate aminotransferase
AUC
area under the curve
BMI
body mass index
CAP
controlled attenuation parameter
CHB
chronic hepatitis B
CHC
chronic hepatitis C
CLD
chronic liver disease
CPA
collagen proportionate area
DAA
direct-acting antiviral
ELF
enhanced liver fibrosis
FIB-4
fibrosis-4
FLIP
fatty liver inhibition of progression
HCC
hepatocellular carcinoma
IFN
interferon
LSM
liver stiffness measure
MR
magnetic resonance
MRE
magnetic resonance elastography
NAFLD
non-alcoholic fatty liver disease
NFS
NAFLD fibrosis score
NITs
non-invasive tests
SVR
sustained virologic response
US
ultrasound
VCTE
vibration-controlled transient elastography
Cited by (0)
© 2020 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).